Recent 8-K filings for MSPR
Highest-materiality recent filing
MSP Recovery signs restructuring term sheet converting $1.2B debt and securing up to $25M working capital
- Virage Recovery waives ~$1.2B claim in exchange for 43% equity stake in the Company.
- MSP principals convert ~$144M debt into Class A common shares.
-
MSP Recovery gets $188K in emergency advances; stock downgraded to OTC Pink
OTC Markets downgraded MSPR to OTC Pink effective May 20, 2026 due to delinquent Form 10-K filing.
-
Hazel advanced $137,500 under Working Capital Credit Facility; total Operational Collection Floor now $7.862M.
-
Hazel Partners advanced $117,500 under the Operational Collection Floor on April 16, 2026; no further funding available.
-
MSP Recovery obtains $0.2M in one-time advances; discloses no further committed liquidity
Hazel Partners advanced $125,000 under existing working capital facility; total Operational Collection Floor raised to $7.607M.
-
MSP Recovery secures $150k in emergency advances; liquidity remains highly constrained
Hazel Partners made a discretionary $75k advance under the Operational Collection Floor, now at ~$7.48M; no further funding committed.
-
MSP Recovery loses director and CFO; obtains two $0.2M emergency advances
Director Ophir Sternberg resigned Feb 13; CFO Francisco Rivas-Vasquez resigned Feb 17. Neither departure due to disagreements.
-
MSP Recovery secures $250K discretionary advance from Hazel; no committed funding remains
Hazel Partners advanced $250K on Jan 26, 2026 under the Operational Collection Floor; total increases now $7.207M since Mar 2025.
-
MSP Recovery gets $300K discretionary advance from Hazel; total floor $6.9M
Hazel advanced $300K on Jan 20, 2026 for operating expenses under one-time discretionary accommodation.
-
Delisted from Nasdaq on Dec 22, 2025; now trades on OTCQB.
-
MSP Recovery obtains $325k discretionary advance from Hazel; no further funding available
One-time $325k advance under operational collection floor for operating expenses; funded by Jan 9, 2026.
-
MSP Recovery furloughs 33% of workforce; public warrants moved to OTCID Basic
Public warrants (MSPRW) transferred to OTCID Basic Market effective Jan 6, 2026, after Nasdaq delisting.
-
MSP Recovery COO Ricardo Rivera departs effective Dec 22, 2025; will advise through year-end
Ricardo Rivera is no longer employed as COO as of December 22, 2025.
-
Nasdaq Panel denies MSPR appeal; common stock delisted Dec 22, moves to OTCQB
On Dec 18, 2025, Nasdaq Hearings Panel denied appeal; suspension effective Dec 22, 2025.
-
SEC concludes investigation of MSP Recovery without recommending enforcement action
SEC staff informed company on Dec 5, 2025 that investigation ended with no intention to recommend enforcement against company, CEO John H. Ruiz, or officers.
-
MSP Recovery receives additional Nasdaq delisting notice for bid price; hearing Dec 11
Additional staff determination: bid price below $1 for 30 consecutive days, non-compliant with Listing Rule 5550(a)(2).
-
MSP Recovery receives Nasdaq delisting notice; Yorkville floor price cut to $0.50
Nasdaq delisting determination received Oct 22, 2025; trading suspended Oct 31 unless hearing requested by Oct 29. Company intends to appeal.
-
MSP Recovery secures $3M Yorkville convertible note, floor price cut to $1; GC resigns
Yorkville agrees to advance up to $3M in convertible notes with 10% OID; net principal increase per advance capped at $1M.
-
MSP Recovery reduces Yorkville SEPA floor price to $1.20 per share from $1.60
Floor price under Yorkville Standby Equity Purchase Agreement reduced from $1.60 to $1.20 per share.
-
MSP Recovery enters two confidential settlements totaling $2.9M in cash
Mediated settlement with P&C insurer includes cash payment, data sharing, and cooperation on Medicare claims.
-
MSP Recovery reduces floor price under Yorkville equity line from $2.00 to $1.60
Floor price under Yorkville SEPA and Notes reduced from $2.00 to $1.60 per share, effective September 15, 2025.
-
MSP Recovery settles Cano Health litigation; all claims dismissed with prejudice
Settlement agreement executed on September 8, 2025, between MSP Recovery, LLC and Cano Health, LLC.
-
MSP Recovery lowers floor price under Yorkville SEPA from $3.50 to $2.00 per share
Floor price reduced to $2.00 per share effective September 5, 2025.
-
MSP Recovery signs non-binding term sheet for up to $55M secured delayed draw loan facility
Tranche A up to $10M (initial $5M funded at close; $5M discretionary).
-
MSP Recovery effects 1-for-7 reverse stock split to regain Nasdaq compliance
Reverse split approved Aug 18, effective Sept 1, 2025 at 11:59 PM.
-
Jury awards $12.7M against MSP Recovery LLC; company and CEO exonerated on fraud claims
Jury exonerated MSP Recovery, Inc. and CEO John H. Ruiz on all fraud and misrepresentation claims.
-
MSP Recovery shareholders approve reverse stock split and warrant exercise shares
Approved Charter amendment for reverse stock split at ratio between 1:2 and 1:7; Board selects final ratio.
-
MSP Recovery issues $750K convertible note to Yorkville; annual meeting reelects directors
Issued sixth convertible note to Yorkville for $0.75M, net proceeds ~$0.71M after OID; disbursed in two $0.36M advances on Aug 8 and Aug 15.
-
MSP Recovery lowers SEPA floor price to $0.50 from $1.00
Floor Price under Yorkville SEPA reduced to $0.50 per share, effective August 5, 2025.
-
MSP Recovery issues $0.75M convertible note to Yorkville; replaces auditor Deloitte with Baker Tilly
Issued fifth convertible note for $0.75M under SEPA; net proceeds $0.71M; 5% interest, convertible at 95% of 5-day VWAP (floor $1.00), maturity March 2027.
-
Maryland Supreme Court upholds MSP Recovery's assignments, allowing GEICO class action to proceed
Maryland's highest court unanimously ruled assignments from Medicare Advantage Organizations are valid and not champertous.
-
MSP Recovery amends Nomura note to ~$33.6M, issues $0.75M Yorkville convertible note
Amended Nomura note to ~$33.6M principal; Nomura waives up to $3M of Yorkville SEPA proceeds.
-
MSP Recovery restructuring term sheet terminated by Hazel and Virage; floor price reduced to $1.00
Hazel terminated Apr 10 term sheet on May 30 citing missed definitive-agreement deadline; funded $0.8M advance on June 2.
-
Nomura note principal raised to $32.7M (from $30.0M), maturity extended to November 30, 2026.
-
MSP Recovery receives Nasdaq delisting notice; stockholders' equity negative $128M
Nasdaq notified MSP Recovery of non-compliance with minimum stockholders' equity requirement.
-
Virage Recovery waives ~$1.2B claim in exchange for 43% equity stake in the Company.
-
MSP Recovery term sheet with Virage to issue 33.3% of Class A stock to settle MTA obligations
Virage may exercise warrants to acquire 33 1/3% of outstanding Class A common stock at $0.0025/share.
Materiality & sentiment trend
Max materiality 0.90 · Median 0.65 · Most common event other_material